Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.
Press releases published on May 15, 2025
كيتا تكشف توجهات توصيل الطعام في السعودية للربع الأول من 2025
EIN Presswire
·
May 15, 2025
RIYADH, RIYADH PROVINCE, SAUDI ARABIA, May 15, 2025 /EINPresswire.com/ -- أعلنت "كيتا"، الذراع الدولية لشركة "ميتوان" الصينية العملاقة في خدمات التوصيل حسب الطلب، عن تقريرها للربع الأول من عام 2025، كاشفة عن توجهات طلبات السعوديين، وما يطلبونه، وأين …
Keeta reveals Saudi’s Food Delivery Trends in Q1 2025
EIN Presswire
·
May 15, 2025
RIYADH, RIYADH PROVINCE, SAUDI ARABIA, May 15, 2025 /EINPresswire.com/ -- Keeta, the international subsidiary of Meituan, China’s on-demand delivery giant, has released Q1 2025 insights, revealing what the Saudi population ordered, where food trends are …
Dr. Jose Arnold Tariga from the USA Selected as Finalist for Aster Guardians Global Nursing Award 2025 Worth USD 250,000
GlobeNewswire
·
May 15, 2025
Boston/Dubai, May 15, 2025 (GLOBE NEWSWIRE) -- Dr. Jose Arnold Tariga, a Filipino-American nurse leader and educator from Boston, USA, selected among top 10 finalists from over 100,000 global entries across 199 countries Winner to be announced at a grand …
EVA AI Launches First Real-Time AI Antivirus for Web3 to Block On-Chain Threats
GlobeNewswire
·
May 15, 2025
DUBAI, United Arab Emirates, May 15, 2025 (GLOBE NEWSWIRE) -- EVA AI - a leading provider of decentralized security solutions and one of Q1’s top-performing on-chain projects - has launched EVA Sentinel Extension, the first AI-powered antivirus built …
Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
GlobeNewswire
·
May 15, 2025
CHICAGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Silo Pharma Announces Pricing of $2 Million Public Offering
GlobeNewswire
·
May 15, 2025
SARASOTA, FL, May 15, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the pricing of a public …
Wix Aims to Disrupt the Design Experience with Wixel, The Next-Generation AI-Powered Visual Design Platform for Anyone
GlobeNewswire
·
May 15, 2025
Wix is redefining creative empowerment with the launch of Wixel – a standalone AI-powered design platform that brings the most advanced visual design capabilities into a single intuitive interface NEW YORK – Wix.com Ltd. (NASDAQ: WIX), the leading SaaS …
High Grade at Globex’s Carp Fluorspar Property, Nevada
GlobeNewswire
·
May 15, 2025
ROUYN-NORANDA, Quebec, May 15, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
GlobeNewswire
·
May 15, 2025
WARSAW, Poland, May 15, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …
SELLAS Life Sciences Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML
GlobeNewswire
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025
GlobeNewswire
·
May 15, 2025
Positive interim 2-week safety and biomarker results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (“IPF”) Continued momentum with completed patient enrollment for the 6-week interim analysis (n=24) …
ParaZero to Present Next-Generation Drone Safety Innovations & New CUAS Net Launcher at XPONENTIAL 2025
GlobeNewswire
·
May 15, 2025
Kfar Saba, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense Counter UAS systems, is set to …
CorMedix Inc. to Participate in the RBC Global Healthcare Conference
GlobeNewswire
·
May 15, 2025
BERKELEY HEIGHTS, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the RBC …
Reflect Scientific Advances Market Presence by Transitioning from OTCQB to OTCIQ
GlobeNewswire
·
May 15, 2025
OREM, Utah, May 15, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of innovative cryogenic technologies for the life sciences and biotech industries, today announced that it is actively transitioning from the OTCQB Venture …
Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire
·
May 15, 2025
In vitro testing with CDI-988 demonstrated superior broad-spectrum antiviral activity against major norovirus variants BOTHELL, Wash., May 15, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial …
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
GlobeNewswire
·
May 15, 2025
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has received approval from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic …
Bitcoin Solaris Launches Enterprise-Grade Security Framework Ahead of Nova App Release
GlobeNewswire
·
May 15, 2025
TALLINN, Estonia, May 15, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris has officially rolled out its enterprise-grade security framework, establishing the technical foundation for the upcoming Nova App launch and broader public participation in its blockchain …
Polpharma Group plaide en faveur d’une action urgente en vue de garantir aux patients européens un accès équitable et précoce aux médicaments
GlobeNewswire
·
May 15, 2025
VARSOVIE, Pologne, 15 mai 2025 (GLOBE NEWSWIRE) -- Polpharma Group, acteur pharmaceutique de première importance, enjoint l’Union européenne à arrêter des mesures décisives pour finaliser la réforme du secteur pharmaceutique et renforcer la capacité du …
Skyharbour and JV Partner Orano to Commence Extensive Summer 2025 Drilling Program at Preston Uranium Project
GlobeNewswire
·
May 15, 2025
Vancouver, BC, May 15, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that its joint-venture partner, Orano Canada Inc. (“Orano”), will commence a …
Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
May 15, 2025
- Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - - Phase 2 MoonStone trial in Relapsing Multiple Sclerosis enrollment concluding; topline results expected early in the fourth quarter …